Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Helium Stewardship Act of 2013
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 the Responsible Helium Administration and Stewardship Act
Helium Stewardship Act of 2013
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527, the Responsible Helium Administration and Stewardship Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · fourth_quarter · Q4
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Need for tranparency on the CMS preventative maintenance directive for medical equipment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · third_quarter · Q3
Source: Senate LDA
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Need for tranparency on the CMS preventative maintenance directive for medical equipment.
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Interstate Horseracing Improvement Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S 3187 Food and Drug Administration Safety and Innovation Act; (Provisions related to medical devices.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.)
Preserving Access to Life-Saving Medications Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
Preserving Access to Life-Saving Medications Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Regulatory Accountability Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Guidance Accountability and Transparency Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Premarket Predictability Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Counterfeit Drug Penalty Enhancement Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
Counterfeit Drug Penalty Enhancement Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Foreign Counterfeit Prevention Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Foreign Counterfeit Prevention Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
SAFE DOSES Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
SAFE DOSES Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
Ban Poisonous Additives Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
Ban Poisonous Additives Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436 Healthcare Cost Reduction Act of 2012; (Provisions related to medical device tax.) S 398 Energy Efficiency National Consensus Alliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Save Our Medical Devices Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Regulatory Flexibility Improvements Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436 Healthcare Cost Reduction Act of 2012; (Provisions related to medical device tax.) S 398 Energy Efficiency National Consensus Alliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.)
Regulatory Flexibility Improvements Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
To require those applying for, and renewing, SCHIP, TAA, and ATAA benefits to present documentation proving both citizenship and identity in order to receive those benefits.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Online Job Training Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Congressional Pay Reform Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
To permit the televising of Supreme Court proceedings.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Positive Alternatives Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Visa Waiver Program Expansion Act of 2010
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
Temporary Judgeships and Bankruptcy Judgeships Act of 2010
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Small Business Paperwork Mandate Elimination Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Revoke Excessive Policies that Encroach on American Liberties (REPEAL) Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Preserving Access to Life-Saving Medications Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
To repeal the Patient Protection and Affordable Care Act and the health care-related provisions in the Health Care and Education Reconciliation Act of 2010 and to amend title 5, United States Code, to establish a national health program administered by the Office of Personnel Management to offer Federal employee health benefits plans to individuals who are not Federal employees, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Ban Poisonous Additives Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Ban Poisonous Additives Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Ban Poisonous Additives Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Health Care Cost Reduction Act of 2012
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Medicare Decisions Accountability Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Save Our Medical Devices Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Save Our Medical Devices Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Save Our Medical Devices Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
To repeal the information reporting requirements added by the Patient Protection and Affordable Care Act.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
To repeal the expansion of information reporting requirements for payments of $600 or more to corporations, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Patients' Freedom to Choose Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Affordable Health Care Expansion Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
American Research and Competitiveness Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
American Research and Competitiveness Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
To require those applying for, and renewing, SCHIP, TAA, and ATAA benefits to present documentation proving both citizenship and identity in order to receive those benefits.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To require those applying for, and renewing, SCHIP, TAA, and ATAA benefits to present documentation proving both citizenship and identity in order to receive those benefits.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Online Job Training Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Online Job Training Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Congressional Pay Reform Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Congressional Pay Reform Act of 2009
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
To permit the televising of Supreme Court proceedings.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
To permit the televising of Supreme Court proceedings.
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Positive Alternatives Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Positive Alternatives Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Visa Waiver Program Expansion Act of 2010
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
Need for tranparency on the CMS preventative maintenance directive for medical equipment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · second_quarter · Q2
HR 527, the Responsible Helium Administration and Stewardship Act
FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding. FY2014 Appropriations FDA and HHS HR 933, the Consolidated and Further Continuing Appropriations Act
Medicare Sustainable Growth Rate Doc fix Provisions related to CMS draft guidance on Service
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · first_quarter · Q1
FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding. FDASIA (S 3187, 112th Congress) as it regards to implementation of FDA funding HR 933 the Consolidated and Further Continuing Appropriations Act
HR 527 the Responsible Helium Administration and Stewardship Act
Medicare Sustainable Growth Rate Doc fix
Medical device tax implementation FY 2014 Presidents Budget, those sections relating to Pharmacy rebates and healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · second_quarter · Q2
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
S 3187 Food and Drug Administration Safety and Innovation Act; (Provisions related to medical devices.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.)
HR 436 Healthcare Cost Reduction Act of 2012; (Provisions related to medical device tax.) S 398 Energy Efficiency National Consensus Alliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.)
S 3187 Food and Drug Administration Safety and Innovation Act; (Provisions related to medical devices.)
S 3187 Food and Drug Administration Safety and Innovation Act; (Provisions relating to medical devices.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
HR 658 FAA Modernization and Reform Act of 2012; (Provisions related to transportation of lithium cells and batteries.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · first_quarter · Q1
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · fourth_quarter · Q4
HR 658/S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions relating to transportation of Lithium batteries.)
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
HR 658/S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions related to transportation of Lithium batteries.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · third_quarter · Q3
HR 942 The American Research and Competitiveness Act of 2011; (Sections reauthorizing R&D tax credits.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · second_quarter · Q2
HR 1249 America Invents Act; (All sections relating to patent reform, provisions related to first to file, fees and prior user rights, provisions related to intellectual property rights.) S 23 Patent Modernization Act of 2011; (Provisions related to intellectual property rights, patent reform, provisions related to first to file, fees and proper user rights.)
HR 658/S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions related to transportation of Lithium batteries.)
HR 658/S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions related to transportation of Lithium batteries.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · first_quarter · Q1
S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · fourth_quarter · Q4
HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.)
HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.)
HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.) S 510 FDA food Safety Modernization Act: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply; (Monitoring provisions of the bill; All sections.) HR 2400 Strategies to address antimicrobial resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009: A reform of the law on food safety protection; (all provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 753 the Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 1523/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4994 Medicare and Medicaid Extenders Act of 2010; (Sections pertaining to competitive bidding of DME.) S 3653 Health Care Bureaucrats Elimination Act; (Sections pertaining to the IPAB.) HR 2751 FDA Food Safety Modernization Act; (Sections pertaining to inspections.) HR 3590 Patient Protections and Affordable Care Act; (All provisions relating to healthcare) HR 4872 The Healthcare and Education Reconciliation Act of 2010; (Provisions relating to healthcare.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · third_quarter · Q3
HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act 2009: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety. Monitoring food safety provisions. All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 510 FDA Food Safety Modernization Act: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply; (Monitoring provisions of the bill.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010"; (Sections pertaining to AMP, and allocations systems.) S.AMDT 4369 to HR 4213 In the nature of a substitute; (Sections pertaining to AMP, and allocations systems.) HR 6228/S 593 The Ban Poinsonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphneol-A containing products.) S 753 the Children's Safe Chemical Act: A ban on food contact materials for children and infants (3years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food, Drug and cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphnol-A in food applications.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.) HR 4872 The Healthcare and Education Reconciliation Act of 2010; (Provisions relating to healthcare.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · first_quarter · 1A
HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.) S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare; all provisions related to competitive acquisition for durable medical equipment and prosthetics, orthotics, and supplies.).) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.) HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3790 To Amend Title XVIII of the Social Security Act to repeal the Medicare competitive aquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); (All provisions related to competitive acquistionf for durable medical equipment and prosthetics, orthotcs, and supplies.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · second_quarter · Q2
HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over Antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part of Bisphenol-A or could release Bisphenol-a into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 3962 Affordable Health Care for America Act; (Provisions related to subtitle, A,B,C, and D.) HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010" (Sections pertaining to AMP, and allocation systems; all provisions related to pharmaceuticals and medical devices) S.Amdt 4369 to HR 4213 In the Nature of a substitute; (Sections pertaining to AMP, and allocation systems.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.) S 1142 the "Informed Health Care Decisions Making Act of 2009; (sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; All provisions related to pharmaceuticals and medical devices.) HR 4899 Making Emergency Supplemental Appropriations for Fiscal Year 2010; (All provisions related to pharmaceuticals and medical devices.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · first_quarter · Q1
HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.) S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.) HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · fourth_quarter · Q4
HR 1409/S 560 Employee Free Choice Act; (Provisions related to card check.)
S 515 Patent Reform Act of 2009; (Provisions relating to apportionment of damages.)
HR 2997/S 1406 Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2010, and for other purposes; (all provisions related to agriculture research funding, funding of conservation programs and funding of USDA agencies indcluding APHIS and FAS.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · third_quarter · Q3
S 515 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to apportionment of damages.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · second_quarter · Q2
S 515 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to apportionment of damages.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · first_quarter · Q1
S. 515 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to apportionment of damages.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · second_quarter · Q2
H.R. 1293 Access to Medicare Imaging Act of 2007; (Provisions on ensuring Medicare beneficiaries have access to medical imaging procedures.)
FY 2009 Commerce, Justice, and Science Appropriations Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
FY 2009 Commerce, Justice, and Science Appropriations Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · first_quarter · Q1
S 1145 Patent Reform Act; (Provisions on patent protection with a focus on apportionment of damages.)
HR 1293 Access to Meicare Imaging Act of 2007; (Provisions on ensuring Medicare beneficiaries have access to medical imaging procedures.)
FY 2009 Commerce, Justice, and Science Appropriaions Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
HR 527 Regulatory Reform Improvement Act of 2011; (Provisions relating to reducing the regulatory process timeline.) S 398 Energy Efficiency National Consensus Appliance Agreement Act of 2011; (Provisions relating to energy tax credits.) HR 3010 Regulatory Accountability Act; (Provisions relating to reducing the regulatory process timeline.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.)
HR 658/ S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions related to transportation of lithium batteries.)
HR 658/S 223 FAA Air Transportation Modernization and Safety Improvement Act; (Provisions related to transportation of Lithium batteries.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1249/S 23 America Invents Act; (Provisions related to false markings, and other provisions that could affect agriculture; provisions related to patent reform; provisions related to first to file, fees and prior user rights.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1249 America Invents Act; (All sections relating to patent reform) S 23 America Invents Act; (Provisions related to patent reform, provisions related to patent timing filing, provisions related to false markings and other provisions that could affect agriculture.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.)
HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 515 A bill to amend title 35, US Code to provice for patent reform; (Sect. 4; Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisions related to Post Grant Procedures.)
HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.)
HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.) HR 4394 Decabromine Elimination and Control Act; (Strategy for input into the bill.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 515 A bill to amend title 35, US Code to provice for patent reform; (Sect. 4; Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisions related to Post Grant Procedures.)
HR 1260/S 515 Patent Reform Act of 2009; (Provisions related to apportionment of damages.) HR 4394 Decabromine Elimination and Control Act; (Strategy for input into the bill.)
HR 1409/S 560 Employee Free Choice Act of 2009; (Provisions related to card check.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 515 A bill to amend title 35, US Code to provide for patent reform; (sec. 4: Provisions related to the right of the inventor to obtain damages, Sect. 5: Provisons related to Post Grant Procedures, Provisions relating to IPP corporate protection, Provisions relating to apportionment of damages) HR 1260 Patent Reform Act of 2009; (Provisions relating to apportionment of damages.)
HR 6228/S 593 The Ban Poisonous Act of 2009, A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (all provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol -A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All provisions relating to follow on biologics.) S 1142 The "Informed Health Care Decisions Making Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healty Americans Act; (Provisions relating to Medicare.) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provisions relating to healthcare) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs, provisions related to subtitles A,B, C and D.) Senate: Patient Protection & Affordable Care Act; (All provisions relating to health care.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 1549/S 619 the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisons in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and cosmetic act to improve the safety of food in the global market, and for other purposes.) HR 3519/S 1709 Veterinary Services Investment Act (Support for legislation.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.) S 510 Food Safety Modernization Act; (Provisions relating to strategy for comments.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1145 Patent Reform Act; (Provisons on patent protection with a focus on apportionment of damages.)
FY 2009 Commerce, Justice, and Science Appropriations Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2009 Commerce, Justice, and Science Appropriaions Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
FY 2009 Commerce, Justice, and Science Appropriaions Act; (Provisions on requesting funding to advance the development of delivery devices for cell therapies to be used to assist astronauts returning from extended missions in space.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE